Skip to content

Clinical trials

Observational Gender Dysphoria trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gender Dysphoria Phase: Observational Country / region: United States Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20182
20194
20202
20212
20221
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting4
Terminated3
Active, not recruiting2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Colorado, Denver2
University of Pittsburgh2
Duke University1
Fenway Community Health1
Mountain Dermatology Specialists1
Northwestern University1
St. Louis University1
University Hospitals Cleveland Medical Center1
University of California, Los Angeles1
University of California, San Francisco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gender Dysphoria16
Infertility2
Insulin Resistance2
Acquired Immunodeficiency Syndrome1
Anxiety Disorders1
Hypogonadism1
Sexually Transmitted Diseases1
Sleep Wake Disorders1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.